Table 3.
Summary of Characteristics of Complementary and Alternative Medicine Measures
| Study characteristic | Number of measures | %a |
|---|---|---|
| Reliability | ||
| Assessed | 6 | 18.8 |
| Validity | ||
| Assessed | 1 | 3.1 |
| Type used | ||
| Closed-ended | 12 | 37.5 |
| Open-ended | 7 | 21.9 |
| Both | 6 | 18.8 |
| Unclear/not assessed | 7 | 21.9 |
| Number used | ||
| ≥5 modalities/≥10 therapies | 22 | 68.8 |
| <5 modalities/<10 therapies | 9 | 28.1 |
| Unclear/not assessed | 1 | 3.1 |
| When useda | ||
| Ever | 7 | 21.9 |
| Currently | 16 | 50.0 |
| Since diagnosis | 7 | 21.9 |
| ANR/RANDb | 1 | 3.1 |
| Unclear/not assessed | 7 | 21.9 |
| Frequency | ||
| Assessed | 1 | 3.1 |
| ANR/RAND | 3 | 9.4 |
| Unclear/not assessed | 28 | 87.5 |
| Dose | ||
| Assessed | 0 | 0 |
| ANR/RAND | 1 | 3.1 |
| Unclear/not assessed | 31 | 96.9 |
| Duration | ||
| Assessed | 0 | 0 |
| ANR/RAND | 2 | 6.3 |
| Unclear/not assessed | 29 | 90.6 |
| How used | ||
| Both | 3 | 9.4 |
| One | 5 | 15.6 |
| No distinction | 18 | 56.3 |
| ANR/RAND | 5 | 15.6 |
| Unclear/not assessed | 1 | 3.1 |
| Study characteristic | Number of measures | % |
|---|---|---|
| Reasons | ||
| Assessed | 6 | 18.8 |
| ANR/RAND | 3 | 9.4 |
| Unclear/Not assessed | 23 | 71.9 |
| Disclosure | ||
| Assessed | 3 | 9.4 |
| ANR/RAND | 2 | 6.3 |
| Unclear/Not assessed | 27 | 84.4 |
| Satisfaction | ||
| Assessed | 0 | 0 |
| ANR/RAND | 0 | 0 |
| Unclear/Not assessed | 32 | 100.0 |
| Perceived efficacy | ||
| Assessed | 8 | 25.0 |
| ANR/RAND | 3 | 9.4 |
| Unclear/Not assessed | 21 | 65.6 |
| Information source | ||
| Assessed | 5 | 15.6 |
| ANR/RAND | 3 | 9.4 |
| Unclear/Not assessed | 24 | 75.0 |
| Expense | ||
| Assessed | 2 | 6.3 |
| ANR/RAND | 1 | 3.1 |
| Unclear/Not assessed | 29 | 90.6 |
a
Percent sums to greater than 100% because, in some cases, studies assessed more than one construct.
b
ANR, assessed but not reported; RAND, reported but assessment not described.